Triola Anna Diaz 4
4 · Entasis Therapeutics Holdings Inc. · Filed Jul 20, 2021
Insider Transaction Report
Form 4
Triola Anna Diaz
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-07-19+100,000→ 100,000 totalExercise: $2.49Exp: 2031-07-18→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on July 19, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.